Clinical trial Recruiting at 1 site Phase 3 Interventional Ages 10 to 18

Methadone-enhanced recovery for children having posterior spine fusion

Official title: Prospective Randomized Evaluation of Analgesia for Spine Fusion Elective Surgery in Children (PRECISE Spine Trial)

Run by University of Pittsburgh · NCT06626503 · Data updated 2026-11-12

This trial will test whether a multidose methadone-based enhanced recovery protocol reduces pain and opioid use in children (ages 10–17) undergoing posterior spine fusion for idiopathic scoliosis.

More Idiopathic Scoliosis trials

Quick facts

PhasePhase 3
Study typeInterventional
Ages10 Years to 18 Years
SexAll
Enrollment500 (estimated)
SponsorUniversity of Pittsburgh
Academic / other
Locations4 sites (Indianapolis, Indiana and 3 other locations)
StatusRecruiting
StartedOctober 30, 2025
Main results expectedJanuary 31, 2029
Study endsAugust 31, 2029
Registry record updatedOctober 7, 2026
Trial IDNCT06626503 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 10 to under 18 with idiopathic scoliosis scheduled for posterior spine fusion, ASA physical status 1–2, and who can read/speak English or Spanish are ideal candidates.

Probably not a fit

Patients who are pregnant, allergic to methadone, have prolonged QTc, recent opioid use, severe sleep apnea, significant organ disease, or are taking strong CYP450 inhibitors are likely to be excluded or may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter, randomized Phase 3 trial compares a standardized multidose methadone-based enhanced recovery after surgery (ERAS) protocol to a non-methadone standard-of-care analgesic approach in children undergoing posterior spine fusion. Investigators will collect pharmacokinetic data, genetic information, and clinical and psychological measures to develop precision dosing models for methadone and oxycodone. The study aims to reduce acute pain, total opioid consumption, opioid-related adverse events (including respiratory depression and PONV), and the risk of chronic postsurgical pain. Sites include pediatric specialty centers where participants will be randomized and followed through the perioperative and early postoperative period.

Why it matters

Potential benefit: If successful, this approach could lower postoperative pain, reduce total opioid exposure and opioid-related side effects, and speed recovery for children after spine fusion.

How similar studies have gone: Single-dose intraoperative methadone has reduced postoperative opioid needs in adults and limited pediatric reports exist, but the multidose, precision-genetics ERAS approach in children is largely novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age 10 - \< 18 years
2. American Society of Anesthesiologists (ASA) Physical Status 1 or 2
3. Undergoing PSF for idiopathic scoliosis
4. Participant or legal guardian can speak and read English or Spanish

Exclusion Criteria:

1. Pregnant patients
2. Methadone allergy
3. Preoperative prolonged QTc more than 460 msec (-30 days to 0 day)
4. Subjects undergoing concomitant treatment with known cytochrome P450 inhibitors included in methadone labeling (i.e. macrolides (e.g. erythromycin), azole-antifungal agents (e.g. ketoconazole, voriconazole), protease inhibitors (e.g. ritonavir), fluconazole, SSRIs (e.g. sertraline, fluvoxamine)
5. Preoperative opioid use within 30 days before surgery
6. History of severe sleep apnea, defined as a prior sleep study demonstrating an apnea-hypopnea index (AHI) greater than 10.
7. Significant liver, kidney, neurological disease, developmental delay, or any other co-existing medical condition per discretion of the clinical investigator

Where it's running

  • UPMC Children's Hospital
    Pittsburgh, Pennsylvania, United States
    Recruiting
  • Riley Children's Hospital
    Indianapolis, Indiana, United States
    Not yet recruiting
  • Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio, United States
    Not yet recruiting
  • Texas Children's Hospital
    Houston, Texas, United States
    Not yet recruiting

Study contacts

  • Principal investigator: Senthilkumar Sadhasivam, MD — University of Pittsburgh
  • Study coordinator: Senthilkumar Sadhasivam, MD, MPH, MBA, FASA
  • Email: sadhasivams@upmc.edu
  • Phone: 4126474484

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.